PRICE T ROWE ASSOCIATES INC /MD/ - DYNAVAX TECHNOLOGIES CORP ownership

DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158102. A total of 117 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q2 2014. The put-call ratio across all filers is 0.30 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of DYNAVAX TECHNOLOGIES CORP
ValueSharesWeighting
Q3 2014$294,000
-10.6%
205,8000.0%0.00%
Q2 2014$329,000
-11.1%
205,8000.0%0.00%
Q1 2014$370,000
-54.1%
205,800
-50.0%
0.00%
Q4 2013$806,000
+555.3%
411,600
+300.4%
0.00%
Q3 2013$123,000
+4.2%
102,800
-3.9%
0.00%
Q2 2013$118,000107,0000.00%
Other shareholders
DYNAVAX TECHNOLOGIES CORP shareholders Q2 2014
NameSharesValueWeighting ↓
RA Capital Management 14,036,590$22,459,0002.27%
Broadfin Capital, LLC 15,320,200$24,512,0001.21%
Rhenman & Partners Asset Management AB 1,228,354$1,965,0000.58%
Polar Capital LLP 10,946,861$17,508,0000.37%
Amici Capital, LLC 4,876,100$7,802,0000.25%
Bain Capital Public Equity Management, LLC 5,274,936$8,440,0000.20%
FEDERATED HERMES, INC. 34,115,000$54,584,0000.17%
CLOUGH CAPITAL PARTNERS L P 2,680,700$4,289,0000.14%
WESTFIELD CAPITAL MANAGEMENT CO LP 13,668,111$21,869,0000.13%
HOWARD HUGHES MEDICAL INSTITUTE 433,557$694,0000.12%
View complete list of DYNAVAX TECHNOLOGIES CORP shareholders